Kayentis has defined global and dedicated key indicators, followed for each site, country or study during the active phase of the trial. Alerting the sponsor in real-time allows a risk-based monitoring strategy to be put in place to increase data quality, reduce costs, and generate instant corrective and preventative actions (CAPAs).
- We provide automated and ad hoc dashboards that enable risk-based monitoring. They include weak signals based on our global experience of work with clinical trial sites, with information coming from our Webportal, our project managers (PMs), our data management (DM) activity, and our Support team.
- Together this information gives you a clear view of what may go right or wrong on-site, and allow us or you to put in place appropriate corrective actions immediately if necessary.
Kayentis considers patient engagement to be crucial and determinant of clinical trial success. Patient engagement is key to increasing both the quantity and quality of clinical trials data while ensuring compliance regarding taking the clinical trial drug(s), filling diaries, and remaining actively involved in the trial. These benefits generate overall savings in budget while at the same time increasing a trial’s power.
We work with our clients and partners to develop the most appropriate tools to support patients, and to improve patient engagement and data quality.
- Tools embedded in our eCOA solutions (e.g. alerts, reminders, messages of support and motivation)
- Tools for sites to keep in touch with the subjects and for the subjects to access study details